MedPath

Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Behavioral: Peer support
Registration Number
NCT03394742
Lead Sponsor
University of Jyvaskyla
Brief Summary

This study examines effectiveness of peer support of breast cancer patients. Half of the participants received peer support via telephone in addition to usual care and another half are give the usual care only.

Detailed Description

Seriously sick people need social support to maintain their quality of life. Social support may be given by peers, who have experienced the same.

In this study voluntary participants with recently diagnosed breast cancer were randomly allocated to intervention (N=130) or control (N=130) group. The intervention group received, in addition to usual care, peer support via telephone 1-5 times according to their own preference. The control group received usual care only. Peer support was given by volunteered breast cancer survivors who were educated for giving peer support.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
260
Inclusion Criteria
  • recently diagnosed primary breast cancer
  • no other serious illnesses
  • ability to communicate in Finnish or Swedish (official languages in Finland)
  • ability to fill in the questionnaires
Exclusion Criteria
  • some other serious illnesses
  • inability to communicate in Finnish or Swedish (official languages in Finland)
  • inability to fill in the questionnaires

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention groupPeer supportPeer support group received, in addition to usual care, peer support via telephone 1-5 times according to their own preference. Peer support was started at the time between diagnosis and the beginning of treatments.
Primary Outcome Measures
NameTimeMethod
A change of health-related quality of life (HRQoL).From baseline to 3, 6 and 12 months later.

HRQoL was assessed with a disease-specific instrument EORTC QLQ-30 and its breast cancer specific module BR23.

Secondary Outcome Measures
NameTimeMethod
Satisfaction for lifeBaseline and 3, 6 and 12 months later.

Satisfaction for life was assessed with a questionnaire created for this study.

The use of health care servicesBaseline and 3, 6 and 12 months later.

The use of health care services was assessed with a questionnaire create for this study.

Trial Locations

Locations (1)

Helsinki University Hospital

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath